
    
      Eligible participants (N=400) with an A1c > 7.0% already prescribed a rapid-acting insulin
      will be randomized to one of two groups: (1) One Drop | Premium 'On Track' (i.e., use the One
      Drop | Mobile app with in-app diabetes education accredited by the American Diabetes
      Association with supplemental Afrezza content and a live Certified Diabetes Educator
      messaging in the app, the 'Chrome' Bluetooth-connected blood glucose meter that uploads blood
      glucose values in the app, and 150 test strips per month) in combination with Afrezza
      treatment (n=200) or (2) One Drop | Premium 'On Track' plus their current rapid-acting
      insulin (n=200).
    
  